| Schedule of main differences between IFRS and US GAAP |
| For the three months ended |
|
February 28,
2019 |
|
| |
|
|
|
| Net loss and comprehensive loss in accordance with IFRS |
|
$ |
2,682,650 |
|
| |
|
|
|
|
| Share-based compensation |
|
|
(248,912 |
) |
| Debt issue costs |
|
|
1,190,132 |
|
| |
|
|
|
|
| Net loss and comprehensive loss in accordance with US GAAP |
|
$ |
3,623,870 |
|
| For the six months ended |
|
|
February 28,
2019 |
|
| |
|
|
|
|
| Net loss and comprehensive loss in accordance with IFRS |
|
$ |
8,955,106 |
|
| |
|
|
|
|
| Share-based compensation |
|
|
(497,824 |
) |
| Debt issue costs |
|
|
95,694 |
|
| |
|
|
|
|
| Net loss and comprehensive loss in accordance with US GAAP |
|
$ |
8,552,976 |
|
|
| Schedule of shareholders' equity |
| |
|
February 28,
2019 |
|
| |
|
|
|
| Total shareholders’ equity in accordance with IFRS |
|
$ |
37,942,916 |
|
| |
|
|
|
|
| Components of share capital in accordance with IFRS |
|
|
|
|
| Share capital |
|
|
88,062,341 |
|
| Shares to be issued |
|
|
1,051,950 |
|
| Share option reserve |
|
|
13,931,650 |
|
| Share warrant reserve |
|
|
5,820,603 |
|
| |
|
|
108,866,544 |
|
| Adjustment for: |
|
|
|
|
| Share-based compensation |
|
|
31,050 |
|
| Share capital in accordance with US GAAP |
|
|
108,897,594 |
|
| |
|
|
|
|
| Deficit in accordance with IFRS |
|
|
(70,923,628 |
) |
| Adjustment for: |
| Debt issue costs |
|
|
(95,694 |
) |
| Share-based compensation |
|
|
(31,050 |
) |
| Deficit in accordance with US GAAP |
|
|
(71,050,372 |
) |
| |
|
|
|
|
| Shareholders equity in accordance with US GAAP |
|
$ |
37,847,222 |
|
|